| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.05 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |